封面
市場調查報告書
商品編碼
2166328

周邊生物材料與植入物市場:全球市場預測,2026-2032年

Peripheral Biomaterial Grafts Market - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年,周邊生物材料移植市場將成長至 42.5 億美元,複合年成長率為 7.70%。

主要市場統計數據
基準年 2025 25.3億美元
預計年份:2026年 27.2億美元
預測年份 2032 42.5億美元
複合年成長率 (%) 7.70%

末梢用生物材料移植:概述

末梢用生物材料移植物用於重組和血管外科手術,利用生物來源或合成材料修復組織、建構血管通路或恢復血流。該領域的發展受臨床證據、移植物耐久性、感染控制、外科醫生技術水平、保險報銷條件以及血管和重組醫學專業化程度等因素的影響。選擇何種移植物越來越依賴材料特性與患者的解剖結構、合併症、手術複雜程度、術後追蹤情況的匹配程度。

臨床證據和技術正在重塑移植選擇。

該領域的發展趨勢正朝著旨在提高易操作性、生物相容性、可重塑性以及抗感染和血栓症形成能力的生物材料方向轉變。組織處理、表面改質、去細胞化、影像和微創技術的進步正在影響臨床醫生評估移植效果的方式。同時,監管機構和醫療服務提供者越來越重視能夠證明可追溯性、標準化生產、長期治療效果以及在不同患者群體中安全性的證據。

人工智慧可以增強規劃、監測和證據產生能力。

人工智慧 (AI) 可透過輔助解剖評估、影像學檢查、手術規劃和術後後續觀察支持周邊血管移植的護理。基於代表性且經過臨床檢驗的資料集訓練的機器學習系統,有助於早期識別狹窄、閉塞、感染或組織整合不良等情況。人工智慧還具有改善臨床試驗參與者招募、手術風險分層和檢測與器械性能相關的訊號的潛力,但其應用需要透明的檢驗、網路安全措施、臨床醫生監督以及防止因數據採集異質性而導致的偏差的措施。

區域趨勢反映了可及性和監管成熟度的差異。

北美地區擁有先進的血管醫療服務、完善的報銷機制和強大的臨床研究能力,但醫療服務的可近性因保險公司和醫療服務環境而異。歐洲強調實證醫學、醫療設備監管、跨境標準以及醫院主導的採購。亞太地區高度發展的市場與快速發展的醫療基礎設施並存,本地生產和價格承受能力影響醫療服務的普及。拉丁美洲的特點是依賴進口、公共部門採購以及專科醫生資源分配不均。中東地區對三級醫療和醫療基礎設施的投資正在推進,但採購和監管的協調仍然是一項關鍵挑戰。非洲在外科手術能力、診斷、醫療物資供應和術後追蹤方面存在顯著差異,因此,持久且易於取得的解決方案尤其重要。

經濟和安全集團會影響採購和標準。

東協市場的特點是監管框架、醫療資金籌措模式和專業技能水平各不相同,因此,互通性和可負擔的培訓日益受到關注。金磚國家成員國在臨床基礎設施、國內製造業和公共採購方面存在顯著差異,通常更注重本地生產和技術轉移。歐盟雖然協助協調成員國之間的監管和品質框架,但保險報銷和醫院實施情況仍很大程度上取決於各國的具體情況。七國集團(G7)國家普遍擁有成熟的臨床生態系統和嚴格的證據要求。海灣合作理事會(GCC)國家正在加強轉診網路和先進的醫療設施建設,而北約成員國可能在建立具有韌性的醫療供應鏈、創傷應變能力和醫療服務的連續性方面存在共用的優先事項。

每個國家的實際情況都會影響證據、取得途徑和本地生產。

澳洲和加拿大擁有高標準的臨床水準和地理分散的醫療保健系統,因此病患轉診物流和物資供應的可靠性至關重要。巴西、墨西哥、俄羅斯、印度和中國的公共和私立醫療保健系統各不相同,當地的生產、採購政策和區域差異會影響醫療服務的可近性。法國、德國、義大利、西班牙和英國的醫療體系在歐洲較成熟的環境中運作,但在保險報銷、採購和評估流程方面存在差異。日本和韓國注重先進的醫療設施、品質保證和技術應用,而美國擁有廣泛的專科醫療體系,但面臨複雜的支付方和監管要求。在所有國家,治療效果都取決於外科醫生的培訓、感染預防、術後影像檢查以及再次手術護理的可近性。

優先考慮實證實踐、韌性和以病人為中心的實踐。

產業領導者應建立以臨床重要終點為中心的實證項目,例如通暢率、肢體保留率、感染率、再次手術率、生活品質和長期耐用性。產品開發必須解決操作、解剖適應性、滅菌、儲存以及與影像和新手術的兼容性等問題。各機構應儘早與監管機構、保險公司、外科醫師和病患溝通,以維持健全的上市後監測,並與合格的替代供應商建立供應鏈。訓練、標準化的移植方案、透明的風險溝通和公平的進入策略可以改善實際應用中的治療效果。人工智慧工具只有在其性能得到檢驗、明確的問責機制建立以及持續監測到位後才能實施。

調查方法:基於證據的周邊移植情況整合

本執行摘要整合了基於周邊生物材料移植的既定範圍的臨床、技術、監管、醫療保健系統和供應鏈方面的既有考慮。評估透過對醫療保健基礎設施、採購條件、專家資源、證據預期和應用障礙的定性分析,對目標地區、經濟和安全群體以及國家進行了比較。本摘要不包含市場估算和預測、市場規模、市場佔有率、預測以及公司特定聲明。隨著臨床指引、監管決策、報銷政策和同儕審查證據的更新,本摘要的解讀也應隨之更新。

永續的成果取決於臨床實踐和系統的整合設計。

周邊生物材料移植的應用受到材料科學、手術技術、證據品質、法規、報銷機制和醫療服務可近性等多方面因素的共同影響。最有前景的途徑是將臨床檢驗的表現與實際應用、可靠的供應、技術精湛的團隊和系統的追蹤相結合。那些能夠將創新與患者選擇、透明的證據、負責任的人工智慧應用以及當地的實際情況相結合的領導者,將更有能力提高周邊重組治療的安全性、持久性和公平性。

目錄

第1章:序言

第2章:調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章:人工智慧的累積影響,2026年

第7章 外周生物材料移植市場:依材料類型分類

  • 自然的
    • 膠原蛋白
    • 細胞外基質
    • 纖維蛋白
  • 合成
    • 陶瓷
      • 羥磷石灰
      • 磷酸三鈣
    • 聚合物
      • Pcl
      • PEG
      • PLGA

第8章 周邊生物材料移植市場:依移植類型分類

  • 同種異體移植
  • 自體移植
  • 合成接枝
  • 異質骨移植

第9章 周邊生物材料移植市場:依外形規格

  • 顆粒
  • 糊狀物/膩子
  • 座位
  • 管子

第10章 周邊生物材料移植市場:依應用領域分類

  • 心血管系統
  • 牙科
  • 整形外科
  • 軟組織

第11章 外周生物材料移植市場:依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第12章 周邊生物材料移植市場:依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 周邊生物材料移植市場:依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 周邊生物材料移植市場:依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析,2025年
    • 濃度比(CR)
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析,2025 年
  • 2025年產品系列分析
  • 基準分析,2025 年

第16章:公司簡介

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Checkpoint Surgical, Inc.
  • Collagen Matrix, Inc.
  • Cook Medical LLC
  • CryoLife, Inc.
  • Getinge AB
  • LeMaitre Vascular, Inc.
  • Medtronic plc
  • Salumedica, LLC
  • Teleflex Incorporated
  • Terumo Corporation
  • WL Gore & Associates, Inc.

第17章 主要專家

Product Code: MRR-1F6B55428466

The Peripheral Biomaterial Grafts Market is projected to grow by USD 4.25 billion at a CAGR of 7.70% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.53 billion
Estimated Year [2026] USD 2.72 billion
Forecast Year [2032] USD 4.25 billion
CAGR (%) 7.70%

Peripheral Biomaterial Grafts: Executive Overview

Peripheral biomaterial grafts are used in reconstructive and vascular procedures where biological or synthetic materials support tissue repair, conduit formation, or restoration of blood flow. The field is shaped by clinical evidence, graft durability, infection control, surgeon familiarity, reimbursement conditions, and the availability of specialized vascular and reconstructive care. Adoption decisions increasingly depend on matching material properties to patient anatomy, comorbidities, procedural complexity, and follow-up capacity.

Clinical Evidence and Technology Are Reshaping Graft Selection

The landscape is shifting toward biomaterials designed to improve handling, biocompatibility, remodeling, and resistance to infection or thrombosis. Advances in tissue processing, surface modification, decellularization, imaging, and minimally invasive techniques are influencing how clinicians evaluate graft performance. At the same time, regulators and providers are placing greater emphasis on traceability, standardized manufacturing, long-term outcomes, and evidence that demonstrates safety across diverse patient populations.

Artificial Intelligence Strengthens Planning, Monitoring, and Evidence Generation

Artificial intelligence can support peripheral graft care by assisting anatomical assessment, imaging interpretation, procedural planning, and postoperative surveillance. Machine-learning systems may help identify stenosis, occlusion, infection, or poor tissue integration earlier when trained on representative and clinically validated datasets. AI also has potential to improve trial recruitment, stratify procedural risk, and detect device-performance signals, but implementation requires transparent validation, cybersecurity controls, clinician oversight, and safeguards against bias caused by uneven data availability.

Regional Dynamics Reflect Uneven Access and Regulatory Maturity

North America combines advanced vascular services, established reimbursement pathways, and strong clinical research capacity, while access can vary by payer and care setting. Europe emphasizes evidence, device oversight, cross-border standards, and hospital-based procurement. Asia-Pacific includes sophisticated markets alongside rapidly expanding healthcare infrastructure, with local manufacturing and affordability influencing adoption. Latin America is shaped by import dependence, public-sector purchasing, and uneven specialist access. The Middle East is investing in tertiary care and medical infrastructure, while procurement and regulatory harmonization remain important. Africa faces pronounced disparities in surgical capacity, diagnostics, supply continuity, and postoperative follow-up, making durable and accessible solutions particularly relevant.

Economic and Security Groupings Influence Procurement and Standards

ASEAN markets reflect varied regulatory systems, healthcare financing models, and levels of specialist capacity, encouraging attention to interoperability and affordable training. BRICS members have substantial differences in clinical infrastructure, domestic manufacturing, and public procurement, with local production and technology transfer often important. The European Union supports coordinated regulatory and quality frameworks across member states, although reimbursement and hospital adoption remain nationally determined. G7 countries generally have mature clinical ecosystems and demanding evidence requirements. GCC states are strengthening referral networks and advanced hospitals, while NATO members may share priorities around resilient medical supply chains, trauma capability, and continuity of care.

Country Conditions Shape Evidence, Access, and Local Production

Australia and Canada combine strong clinical standards with geographically dispersed care, making referral logistics and supply reliability relevant. Brazil, Mexico, Russia, India, and China exhibit diverse public and private systems, with local manufacturing, procurement policy, and regional disparities influencing access. France, Germany, Italy, Spain, and the United Kingdom operate within mature European clinical environments, but reimbursement, procurement, and assessment processes differ. Japan and South Korea emphasize advanced hospitals, quality assurance, and technology adoption, while the United States has extensive specialist capacity alongside complex payer and regulatory requirements. Across all countries, outcomes depend on surgeon training, infection prevention, follow-up imaging, and the availability of revision care.

Prioritize Evidence, Resilience, and Patient-Centered Implementation

Industry leaders should build evidence programs around clinically meaningful endpoints, including patency, limb salvage, infection, reintervention, quality of life, and long-term durability. Product development should address handling, anatomical adaptability, sterilization, storage, and compatibility with imaging and emerging procedures. Organizations should engage regulators, payers, surgeons, and patients early; maintain robust post-market surveillance; and design supply chains with qualified backup sources. Training, standardized implantation protocols, transparent risk communication, and equitable access strategies can improve real-world outcomes. AI-enabled tools should be introduced only with validated performance, clear accountability, and continuous monitoring.

Methodology: Evidence-Led Synthesis of Peripheral Graft Conditions

This executive summary uses the defined peripheral biomaterial graft scope and synthesizes established clinical, technological, regulatory, healthcare-system, and supply-chain considerations. The assessment compares the required regions, economic and security groupings, and countries through qualitative analysis of care infrastructure, procurement conditions, specialist availability, evidence expectations, and implementation barriers. It excludes market estimates, market sizing, market shares, forecasts, and company-specific claims. Interpretation should be updated as clinical guidelines, regulatory decisions, reimbursement policies, and peer-reviewed evidence evolve.

Durable Outcomes Will Depend on Integrated Clinical and System Design

Peripheral biomaterial graft adoption is being shaped by the interaction of material science, procedural expertise, evidence quality, regulation, reimbursement, and healthcare access. The strongest path forward combines clinically validated performance with practical deployment, reliable supply, skilled teams, and structured follow-up. Leaders that align innovation with patient selection, transparent evidence, responsible AI use, and regional implementation realities will be better positioned to improve safety, durability, and equity in peripheral reconstructive care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Peripheral Biomaterial Grafts Market, by Material Type

  • 7.1. Introduction
  • 7.2. Natural
    • 7.2.1. Collagen
    • 7.2.2. Extracellular Matrix
    • 7.2.3. Fibrin
  • 7.3. Synthetic
    • 7.3.1. Ceramics
      • 7.3.1.1. Hydroxyapatite
      • 7.3.1.2. Tricalcium Phosphate
    • 7.3.2. Polymers
      • 7.3.2.1. Pcl
      • 7.3.2.2. Peg
      • 7.3.2.3. Plga

8. Peripheral Biomaterial Grafts Market, by Graft Type

  • 8.1. Introduction
  • 8.2. Allograft
  • 8.3. Autograft
  • 8.4. Synthetic Graft
  • 8.5. Xenograft

9. Peripheral Biomaterial Grafts Market, by Form Factor

  • 9.1. Introduction
  • 9.2. Granules
  • 9.3. Paste Putty
  • 9.4. Sheet
  • 9.5. Tube

10. Peripheral Biomaterial Grafts Market, by Application

  • 10.1. Introduction
  • 10.2. Cardiovascular
  • 10.3. Dental
  • 10.4. Orthopedic
  • 10.5. Soft Tissue

11. Peripheral Biomaterial Grafts Market, by End-User

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers
  • 11.3. Hospitals
  • 11.4. Specialty Clinics

12. Peripheral Biomaterial Grafts Market, by Region

  • 12.1. Introduction
  • 12.2. Asia-Pacific
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Europe
  • 12.6. Middle East
  • 12.7. Africa

13. Peripheral Biomaterial Grafts Market, by Group

  • 13.1. Introduction
  • 13.2. ASEAN
  • 13.3. GCC
  • 13.4. European Union
  • 13.5. BRICS
  • 13.6. G7
  • 13.7. NATO

14. Peripheral Biomaterial Grafts Market, by Country

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. United Kingdom
  • 14.7. Germany
  • 14.8. France
  • 14.9. Russia
  • 14.10. Italy
  • 14.11. Spain
  • 14.12. China
  • 14.13. India
  • 14.14. Japan
  • 14.15. Australia
  • 14.16. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. Market Concentration Analysis, 2025
    • 15.2.1. Concentration Ratio (CR)
    • 15.2.2. Herfindahl Hirschman Index (HHI)
  • 15.3. Recent Developments & Impact Analysis, 2025
  • 15.4. Product Portfolio Analysis, 2025
  • 15.5. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. B. Braun Melsungen AG
  • 16.2. Baxter International Inc.
  • 16.3. Checkpoint Surgical, Inc.
  • 16.4. Collagen Matrix, Inc.
  • 16.5. Cook Medical LLC
  • 16.6. CryoLife, Inc.
  • 16.7. Getinge AB
  • 16.8. LeMaitre Vascular, Inc.
  • 16.9. Medtronic plc
  • 16.10. Salumedica, LLC
  • 16.11. Teleflex Incorporated
  • 16.12. Terumo Corporation
  • 16.13. W. L. Gore & Associates, Inc.

17. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Peripheral Biomaterial Grafts Market, Years Considered for the Study
  • FIGURE 2. Global Peripheral Biomaterial Grafts Market, Research Design
  • FIGURE 3. Global Peripheral Biomaterial Grafts Market, Research Framework
  • FIGURE 4. Global Peripheral Biomaterial Grafts Market, Data Triangulation
  • FIGURE 5. Global Peripheral Biomaterial Grafts Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Peripheral Biomaterial Grafts Market Size, by Material Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Peripheral Biomaterial Grafts Market Size, by Material Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Peripheral Biomaterial Grafts Market Size, by Graft Type, 2025 vs 2032 (%)
  • FIGURE 9. Global Peripheral Biomaterial Grafts Market Size, by Graft Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Peripheral Biomaterial Grafts Market Size, by Form Factor, 2025 vs 2032 (%)
  • FIGURE 11. Global Peripheral Biomaterial Grafts Market Size, by Form Factor, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Peripheral Biomaterial Grafts Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 13. Global Peripheral Biomaterial Grafts Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Peripheral Biomaterial Grafts Market Size, by End-User, 2025 vs 2032 (%)
  • FIGURE 15. Global Peripheral Biomaterial Grafts Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Peripheral Biomaterial Grafts Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 17. Global Peripheral Biomaterial Grafts Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Peripheral Biomaterial Grafts Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Peripheral Biomaterial Grafts Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 20. Global Peripheral Biomaterial Grafts Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Peripheral Biomaterial Grafts Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Peripheral Biomaterial Grafts Market Segmentation & Coverage
  • TABLE 2. Global Peripheral Biomaterial Grafts Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 4. Global Natural Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Natural Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Natural Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Collagen Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Collagen Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Collagen Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Extracellular Matrix Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Extracellular Matrix Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Extracellular Matrix Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Fibrin Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Fibrin Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Fibrin Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Synthetic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Synthetic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Synthetic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Ceramics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Ceramics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Ceramics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Hydroxyapatite Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 23. Global Hydroxyapatite Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 24. Global Hydroxyapatite Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 25. Global Tricalcium Phosphate Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 26. Global Tricalcium Phosphate Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 27. Global Tricalcium Phosphate Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 28. Global Polymers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global Polymers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global Polymers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global Pcl Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 32. Global Pcl Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 33. Global Pcl Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 34. Global Peg Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 35. Global Peg Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 36. Global Peg Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 37. Global Plga Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 38. Global Plga Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 39. Global Plga Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 40. Global Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 41. Global Allograft Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 42. Global Allograft Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 43. Global Allograft Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 44. Global Autograft Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 45. Global Autograft Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 46. Global Autograft Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 47. Global Synthetic Graft Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 48. Global Synthetic Graft Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 49. Global Synthetic Graft Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 50. Global Xenograft Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 51. Global Xenograft Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 52. Global Xenograft Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 53. Global Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 54. Global Granules Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 55. Global Granules Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 56. Global Granules Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 57. Global Paste Putty Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 58. Global Paste Putty Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 59. Global Paste Putty Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 60. Global Sheet Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 61. Global Sheet Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 62. Global Sheet Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 63. Global Tube Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 64. Global Tube Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 65. Global Tube Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 66. Global Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 67. Global Cardiovascular Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 68. Global Cardiovascular Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 69. Global Cardiovascular Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 70. Global Dental Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 71. Global Dental Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 72. Global Dental Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 73. Global Orthopedic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 74. Global Orthopedic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 75. Global Orthopedic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 76. Global Soft Tissue Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 77. Global Soft Tissue Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 78. Global Soft Tissue Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 79. Global Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 80. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 81. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 82. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 83. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 84. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 85. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 86. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 87. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 88. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 89. Global Peripheral Biomaterial Grafts Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 90. Asia-Pacific Peripheral Biomaterial Grafts Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 91. Asia-Pacific Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 92. Asia-Pacific Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 93. Asia-Pacific Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 94. Asia-Pacific Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 95. Asia-Pacific Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 96. Asia-Pacific Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 97. Asia-Pacific Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 98. Asia-Pacific Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 99. Asia-Pacific Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 100. North America Peripheral Biomaterial Grafts Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 101. North America Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 102. North America Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 103. North America Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 104. North America Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 105. North America Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 106. North America Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 107. North America Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 108. North America Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 109. North America Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 110. Latin America Peripheral Biomaterial Grafts Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 111. Latin America Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 112. Latin America Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 113. Latin America Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 114. Latin America Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 115. Latin America Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 116. Latin America Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 117. Latin America Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 118. Latin America Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 119. Latin America Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 120. Europe Peripheral Biomaterial Grafts Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 121. Europe Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 122. Europe Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 123. Europe Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 124. Europe Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 125. Europe Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 126. Europe Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 127. Europe Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 128. Europe Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 129. Europe Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 130. Middle East Peripheral Biomaterial Grafts Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 131. Middle East Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 132. Middle East Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 133. Middle East Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 134. Middle East Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 135. Middle East Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 136. Middle East Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 137. Middle East Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 138. Middle East Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 139. Middle East Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 140. Africa Peripheral Biomaterial Grafts Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 141. Africa Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 142. Africa Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 143. Africa Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 144. Africa Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 145. Africa Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 146. Africa Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 147. Africa Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 148. Africa Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 149. Africa Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 150. Global Peripheral Biomaterial Grafts Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 151. ASEAN Peripheral Biomaterial Grafts Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 152. ASEAN Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 153. ASEAN Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 154. ASEAN Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 155. ASEAN Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 156. ASEAN Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 157. ASEAN Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 158. ASEAN Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 159. ASEAN Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 160. ASEAN Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 161. GCC Peripheral Biomaterial Grafts Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 162. GCC Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 163. GCC Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 164. GCC Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 165. GCC Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 166. GCC Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 167. GCC Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 168. GCC Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 169. GCC Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 170. GCC Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 171. European Union Peripheral Biomaterial Grafts Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 172. European Union Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 173. European Union Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 174. European Union Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 175. European Union Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 176. European Union Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 177. European Union Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 178. European Union Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 179. European Union Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 180. European Union Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 181. BRICS Peripheral Biomaterial Grafts Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 182. BRICS Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 183. BRICS Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 184. BRICS Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 185. BRICS Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 186. BRICS Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 187. BRICS Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 188. BRICS Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 189. BRICS Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 190. BRICS Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 191. G7 Peripheral Biomaterial Grafts Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 192. G7 Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 193. G7 Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 194. G7 Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 195. G7 Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 196. G7 Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 197. G7 Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 198. G7 Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 199. G7 Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 200. G7 Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 201. NATO Peripheral Biomaterial Grafts Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 202. NATO Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 203. NATO Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 204. NATO Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 205. NATO Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 206. NATO Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 207. NATO Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 208. NATO Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 209. NATO Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 210. NATO Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 211. Global Peripheral Biomaterial Grafts Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 212. United States Peripheral Biomaterial Grafts Market Size, 2017-2032 (USD Million)
  • TABLE 213. United States Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 214. United States Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 215. United States Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 216. United States Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 217. United States Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 218. United States Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 219. United States Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 220. United States Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 221. United States Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 222. Canada Peripheral Biomaterial Grafts Market Size, 2017-2032 (USD Million)
  • TABLE 223. Canada Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 224. Canada Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 225. Canada Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 226. Canada Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 227. Canada Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 228. Canada Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 229. Canada Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 230. Canada Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 231. Canada Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 232. Mexico Peripheral Biomaterial Grafts Market Size, 2017-2032 (USD Million)
  • TABLE 233. Mexico Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 234. Mexico Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 235. Mexico Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 236. Mexico Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 237. Mexico Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 238. Mexico Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 239. Mexico Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 240. Mexico Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 241. Mexico Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 242. Brazil Peripheral Biomaterial Grafts Market Size, 2017-2032 (USD Million)
  • TABLE 243. Brazil Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 244. Brazil Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 245. Brazil Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 246. Brazil Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 247. Brazil Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 248. Brazil Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 249. Brazil Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 250. Brazil Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 251. Brazil Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 252. United Kingdom Peripheral Biomaterial Grafts Market Size, 2017-2032 (USD Million)
  • TABLE 253. United Kingdom Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 254. United Kingdom Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 255. United Kingdom Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 256. United Kingdom Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 257. United Kingdom Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 258. United Kingdom Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 259. United Kingdom Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 260. United Kingdom Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 261. United Kingdom Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 262. Germany Peripheral Biomaterial Grafts Market Size, 2017-2032 (USD Million)
  • TABLE 263. Germany Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 264. Germany Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 265. Germany Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 266. Germany Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 267. Germany Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 268. Germany Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 269. Germany Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 270. Germany Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 271. Germany Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 272. France Peripheral Biomaterial Grafts Market Size, 2017-2032 (USD Million)
  • TABLE 273. France Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 274. France Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 275. France Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 276. France Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 277. France Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 278. France Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 279. France Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 280. France Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 281. France Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 282. Russia Peripheral Biomaterial Grafts Market Size, 2017-2032 (USD Million)
  • TABLE 283. Russia Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 284. Russia Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 285. Russia Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 286. Russia Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 287. Russia Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 288. Russia Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 289. Russia Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 290. Russia Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 291. Russia Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 292. Italy Peripheral Biomaterial Grafts Market Size, 2017-2032 (USD Million)
  • TABLE 293. Italy Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 294. Italy Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 295. Italy Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 296. Italy Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 297. Italy Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 298. Italy Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 299. Italy Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 300. Italy Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 301. Italy Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 302. Spain Peripheral Biomaterial Grafts Market Size, 2017-2032 (USD Million)
  • TABLE 303. Spain Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 304. Spain Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 305. Spain Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 306. Spain Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 307. Spain Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 308. Spain Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 309. Spain Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 310. Spain Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 311. Spain Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 312. China Peripheral Biomaterial Grafts Market Size, 2017-2032 (USD Million)
  • TABLE 313. China Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 314. China Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 315. China Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 316. China Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 317. China Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 318. China Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 319. China Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 320. China Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 321. China Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 322. India Peripheral Biomaterial Grafts Market Size, 2017-2032 (USD Million)
  • TABLE 323. India Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 324. India Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 325. India Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 326. India Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 327. India Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 328. India Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 329. India Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 330. India Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 331. India Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 332. Japan Peripheral Biomaterial Grafts Market Size, 2017-2032 (USD Million)
  • TABLE 333. Japan Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 334. Japan Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 335. Japan Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 336. Japan Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 337. Japan Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 338. Japan Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 339. Japan Peripheral Biomaterial Grafts Market Size, by Form Factor, 2017-2032 (USD Million)
  • TABLE 340. Japan Peripheral Biomaterial Grafts Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 341. Japan Peripheral Biomaterial Grafts Market Size, by End-User, 2017-2032 (USD Million)
  • TABLE 342. Australia Peripheral Biomaterial Grafts Market Size, 2017-2032 (USD Million)
  • TABLE 343. Australia Peripheral Biomaterial Grafts Market Size, by Material Type, 2017-2032 (USD Million)
  • TABLE 344. Australia Peripheral Biomaterial Grafts Market Size, by Natural, 2017-2032 (USD Million)
  • TABLE 345. Australia Peripheral Biomaterial Grafts Market Size, by Synthetic, 2017-2032 (USD Million)
  • TABLE 346. Australia Peripheral Biomaterial Grafts Market Size, by Ceramics, 2017-2032 (USD Million)
  • TABLE 347. Australia Peripheral Biomaterial Grafts Market Size, by Polymers, 2017-2032 (USD Million)
  • TABLE 348. Australia Peripheral Biomaterial Grafts Market Size, by Graft Type, 2017-2032 (USD Million)
  • TABLE 349. A